iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$89.67−1.16 (-1.28%)
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
iRhythm r&d expenses
Research and development expenses are spending on new products and technology.
iRhythm's R&D Expenses for the twelve months ending Jun 30, 2026 was $83.28M, up 7.7% year over year. For fiscal 2025 it was $84.61M, up 18.4% from the year before. Over ten years it grew 29.6% a year on average. The highest annual figure on record is $84.61M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $84.61M | +18.4% |
| FY2024 | Dec 31, 2024 | $71.46M | +18.6% |
| FY2023 | Dec 31, 2023 | $60.24M | +29.3% |
| FY2022 | Dec 31, 2022 | $46.61M | +20.5% |
| FY2021 | Dec 31, 2021 | $38.67M | -6.4% |
| FY2020 | Dec 31, 2020 | $41.33M | +10.8% |
| FY2019 | Dec 31, 2019 | $37.30M | +78.8% |
| FY2018 | Dec 31, 2018 | $20.86M | +57.3% |
| FY2017 | Dec 31, 2017 | $13.27M | +85.5% |
| FY2016 | Dec 31, 2016 | $7.15M | +12.6% |
| FY2015 | Dec 31, 2015 | $6.35M | +11.4% |
| FY2014 | Dec 31, 2014 | $5.70M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.84M | -5.6% |
| Q1 FY2026 | Mar 31, 2026 | $21.36M | -0.7% |
| Q4 FY2025 | Dec 31, 2025 | $21.05M | +10.3% |
| Q3 FY2025 | Sep 30, 2025 | $21.03M | +34.0% |
| Q2 FY2025 | Jun 30, 2025 | $21.01M | +6.7% |
| Q1 FY2025 | Mar 31, 2025 | $21.52M | +26.6% |
| Q4 FY2024 | Dec 31, 2024 | $19.08M | +23.8% |
| Q3 FY2024 | Sep 30, 2024 | $15.69M | -3.8% |
| Q2 FY2024 | Jun 30, 2024 | $19.69M | +44.0% |
| Q1 FY2024 | Mar 31, 2024 | $16.99M | +14.5% |
| Q4 FY2023 | Dec 31, 2023 | $15.42M | +21.6% |
| Q3 FY2023 | Sep 30, 2023 | $16.31M | +42.5% |
| Q2 FY2023 | Jun 30, 2023 | $13.68M | +14.5% |
| Q1 FY2023 | Mar 31, 2023 | $14.84M | +40.8% |
| Q4 FY2022 | Dec 31, 2022 | $12.68M | +6.8% |
| Q3 FY2022 | Sep 30, 2022 | $11.45M | +31.8% |
| Q2 FY2022 | Jun 30, 2022 | $11.95M | +24.3% |
| Q1 FY2022 | Mar 31, 2022 | $10.54M | +23.9% |
| Q4 FY2021 | Dec 31, 2021 | $11.87M | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $8.69M | -0.9% |
| Q2 FY2021 | Jun 30, 2021 | $9.61M | -23.4% |
| Q1 FY2021 | Mar 31, 2021 | $8.51M | +1.1% |
| Q4 FY2020 | Dec 31, 2020 | $11.60M | +25.2% |
| Q3 FY2020 | Sep 30, 2020 | $8.77M | -35.0% |
| Q2 FY2020 | Jun 30, 2020 | $12.54M | +60.1% |
| Q1 FY2020 | Mar 31, 2020 | $8.42M | +25.6% |
| Q4 FY2019 | Dec 31, 2019 | $9.27M | +30.8% |
| Q3 FY2019 | Sep 30, 2019 | $13.50M | +165.4% |
| Q2 FY2019 | Jun 30, 2019 | $7.83M | +68.6% |
| Q1 FY2019 | Mar 31, 2019 | $6.70M | +65.7% |
| Q4 FY2018 | Dec 31, 2018 | $7.08M | +73.7% |
| Q3 FY2018 | Sep 30, 2018 | $5.09M | +34.2% |
| Q2 FY2018 | Jun 30, 2018 | $4.65M | +67.4% |
| Q1 FY2018 | Mar 31, 2018 | $4.04M | +54.3% |
| Q4 FY2017 | Dec 31, 2017 | $4.08M | +77.1% |
| Q3 FY2017 | Sep 30, 2017 | $3.79M | +131.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.78M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.64M | – |
See a number that looks wrong?